New heart device aims to fix irregular rhythm during surgery
NCT ID NCT07410962
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a new device that uses pulsed electric fields to treat atrial fibrillation (an irregular heartbeat) during planned heart surgery. Sixteen adults will receive the treatment and be followed for 6 months to check safety and whether the heart rhythm stays normal. The goal is to see if this approach is safe and works well enough for larger studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Cardiac pulsed field ablation device and disposable electrode
- What this could lead to
- If successful, this could offer a safer, more precise way to treat atrial fibrillation during heart surgery, potentially reducing complications.
- What could go wrong
- This is a very early, small trial with only 16 people. The device may not work as hoped, and risks include serious bleeding, stroke, or heart attack.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION FLUTTERING are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.